AI Dynamics

Global AI News Aggregator

Prioritizing Risk Regulation: Drugs, Viruses, and AGI Research

Actually, I'd personally say it should be much easier to go sell a new drug that only injures voluntary customers in the worst case? But do shut down gain-of-function virus research which could kill millions of non-customers. And shut down AGI research that could kill everyone.

→ View original post on X — @esyudkowsky,

Commentaires

Leave a Reply

Your email address will not be published. Required fields are marked *